{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_18824", "batch_size": 200, "batch_pos": 22, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment is a factual statement without high-potency verbs, metaphors, or alert phrases.", "method": "llm_batch", "batch_id": "batch_2_6012", "batch_size": 200, "batch_pos": 199, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "The verbs 'secures' and 'includes' are not on the list of moderate verbs for Q3, although scale is present.", "method": "llm_batch", "batch_id": "batch_3_20908", "batch_size": 200, "batch_pos": 164, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_16996", "batch_size": 200, "batch_pos": 160, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "The segment reports facts about a deal without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_20076", "batch_size": 200, "batch_pos": 156, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser combined with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_19064", "batch_size": 200, "batch_pos": 118, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment states deal secures doses, with no bare negation.", "method": "llm_batch", "batch_id": "batch_7_7900", "batch_size": 200, "batch_pos": 99, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "no", "rationale": "The segment describes details of a deal (in EU), not US capability or preparedness.", "method": "llm_batch", "batch_id": "batch_8_7844", "batch_size": 200, "batch_pos": 166, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 9, "answer": "yes", "rationale": "Reports numerical metrics ('up to 665,000 doses', 'further 40 million vaccines') using standard verbs ('secures', 'includes').", "method": "llm_batch", "batch_id": "batch_9_19024", "batch_size": 200, "batch_pos": 144, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
